BRK-B vs GCV
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating operational efficiency and profitability trends. While the company maintains a fortress balance sheet with a Debt/Equity ratio of 0.19 and a Current Ratio of 7.07, the stock is trading at a significant premium to its growth-based intrinsic value of $217.21. Negative YoY revenue and earnings growth, coupled with a bearish technical trend, offset the positive analyst sentiment and long-term historical performance.
GCV exhibits a stable financial profile with a Piotroski F-Score of 6/9 and significant undervaluation relative to its Graham Number ($10.28) and Intrinsic Value ($31.86). The fund is trading at a very low P/E of 4.14 compared to the sector average of 38.37, while maintaining a strong ROE of 24.70%. Despite a bearish technical trend score, the combination of a 10.74% sustainable dividend yield and explosive earnings growth (373.80% YoY) presents a compelling value opportunity.
Compare Another Pair
Related Comparisons
BRK-B vs GCV: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and The Gabelli Convertible and Income Securities Fund Inc. (GCV) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.